• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

Research Brief on 2-Chloro-4-(3,5-dichlorophenyl)benzonitrile (CAS: 1355246-88-6): Recent Advances and Applications

2-Chloro-4-(3,5-dichlorophenyl)benzonitrile (CAS: 1355246-88-6) is a halogenated benzonitrile derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and agrochemical development. This compound, characterized by its unique structural features, has been the subject of recent studies exploring its biological activity, synthetic pathways, and mechanistic insights. This research brief aims to provide a comprehensive overview of the latest findings related to this compound, highlighting its significance in current scientific endeavors.

Recent studies have focused on the synthesis and optimization of 2-chloro-4-(3,5-dichlorophenyl)benzonitrile, with particular emphasis on its role as a key intermediate in the development of novel bioactive molecules. Researchers have employed advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and regioselective halogenation, to achieve high yields and purity of the compound. These methodological advancements have facilitated its use in subsequent derivatization and functionalization processes, enabling the exploration of its pharmacological potential.

In the context of biological activity, 2-chloro-4-(3,5-dichlorophenyl)benzonitrile has demonstrated promising results as a modulator of specific enzymatic pathways. For instance, recent in vitro studies have revealed its inhibitory effects on cytochrome P450 enzymes, suggesting potential applications in the treatment of metabolic disorders. Additionally, its interaction with nuclear receptors has been investigated, with preliminary data indicating its ability to influence gene expression profiles associated with inflammation and cell proliferation. These findings underscore the compound's versatility as a scaffold for drug development.

The agrochemical sector has also shown interest in 2-chloro-4-(3,5-dichlorophenyl)benzonitrile, particularly due to its herbicidal and fungicidal properties. Field trials conducted in 2023 have demonstrated its efficacy in controlling resistant weed species, with minimal environmental impact compared to conventional agrochemicals. Its mode of action, which involves disruption of plant cell wall synthesis, has been elucidated through advanced imaging techniques, providing a foundation for the design of next-generation crop protection agents.

Despite these advancements, challenges remain in the widespread adoption of 2-chloro-4-(3,5-dichlorophenyl)benzonitrile. Issues such as bioavailability, metabolic stability, and potential off-target effects require further investigation. Ongoing research is addressing these limitations through structural modifications and formulation strategies, with the goal of optimizing its therapeutic and agrochemical profiles. Collaborative efforts between academic institutions and industry partners are expected to accelerate the translation of these findings into practical applications.

In conclusion, 2-chloro-4-(3,5-dichlorophenyl)benzonitrile (CAS: 1355246-88-6) represents a compelling case study in the intersection of chemical synthesis and biological application. Its multifaceted utility, coupled with recent methodological breakthroughs, positions it as a valuable tool for researchers in the chemical biology and pharmaceutical sectors. Future studies will likely focus on expanding its scope of application, refining its properties, and exploring its potential in emerging therapeutic areas.

• 5435-92-7(2-Chloro-4-phenylbenzonitrile)
• 544673-46-3([1,1'-Biphenyl]-3-carbonitrile, 4-chloro-)
• 1355248-19-9(2-chloro-4-(3-chloro-4-methylphenyl)benzonitrile)
• 1237137-24-4(2-chloro-4-(4-chlorophenyl)benzonitrile)
• 253679-13-9(3-(3-Chloro-4-methylphenyl)benzonitrile)
• 1068162-79-7(2-chloro-4-(3-chloro-4-cyanophenyl)benzonitrile)
• 1355247-42-5(2-chloro-4-(2-chloro-4-methylphenyl)benzonitrile)
• 1355247-45-8(2-chloro-4-(2-chloro-5-methylphenyl)benzonitrile)
• 1355247-47-0(2-chloro-4-(3-chlorophenyl)benzonitrile)
• 1352318-49-0(4-(3-Chloro-4-methylphenyl)benzonitrile)